Bionomics Total Liabilities 2022-2024 | NEUP
Bionomics total liabilities from 2022 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Bionomics Annual Total Liabilities
(Millions of US $) |
| 2024 |
$10 |
| 2023 |
$7 |
| 2022 |
$6 |
| 2021 |
$5 |
Bionomics Quarterly Total Liabilities
(Millions of US $) |
| 2024-09-30 |
$6 |
| 2024-06-30 |
$10 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$7 |
| 2022-12-31 |
$6 |
| 2022-06-30 |
$6 |
| 2021-06-30 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
